BLAC: Bellevue Life Sciences Acquisition Corp. - Summary | Jitta

Bellevue Life Sciences Acquisition Corp.

NASDAQ:BLAC

Notice
Stock data is unavailable or the company’s delisted.
Price
$3.01
Loss Chance
59.6%
n/aJITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (6)
Recent Business Performance (3)
Financial Strength (19)
Return to Shareholders (16)
Competitive Advantage (5)
Jitta Signs
Debt LevelLow Long Term Debt
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
Recent Business PerformanceEarning decline 761.91% in the last quarter (yoy)
Key Stats
Jitta Score
Jitta Line
n/a
100.00%
2.61
563.99%
2.61
563.99%
4.41
53.66%
3.32
38.04%
2.67
16.43%
COMPANY DESCRIPTION
As of February 14, 2025, Bellevue Life Sciences Acquisition Corp. was acquired by OSR Holdings.Co.,Ltd., in a reverse merger transaction. Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.